Role of community pharmacists in skin cancer screening: A descriptive study of skin cancer risk factors prevalence and photoprotection habits in Barcelona, Catalonia, Spain.

Autor:	Mir JF; Consultant Pharmacist in Research and Projects Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). mir.bonnin@cofb.net., Estrada-Campmany M; Consultant Pharmacist in Research and Projects Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). mestrada@cofb.net., Heredia A; Professional Relations Manager. Barcelona Pharmacists Association (COFB). Barcelona (Spain). aheredia@cofb.net., Rodríguez-Caba C; Head of Department of Continuous Professional Development. Barcelona Pharmacists Association (COFB). Barcelona (Spain). rodriguez.caba@cofb.net., Alcalde M; Community Pharmacist. Dermopharmacy and Medical Devices Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). marta.alcalde@gmail.com., Espinosa N; Dermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). natalia.espinosav08@gmail.com., Monnier J; Dermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). monnierjilliana@gmail.com., Pérez-Anker J; Dermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). javiperezanker@gmail.com., Yélamos O; Dermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). oriol_yelamos@hotmail.com., Puig S; Dermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona; & Biomedical Research Networking Centers Consortium, Institute of Health Carlos III (CIBER-ISCIII). Barcelona (Spain). susipuig@gmail.com., Bosch N; Community Pharmacist. Dermopharmacy and Medical Devices Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). nbosch001@cofb.net., Malvehy J; Dermatologist. Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).Centro de Investigación Biomédica en Red (CIBER), Instituto Carlos III, Barcelona (Spain). jmalvehy@gmail.com.
Jazyk:	angličtina
Zdroj:	Pharmacy practice [Pharm Pract (Granada)] 2019 Jul-Sep; Vol. 17 (3), pp. 1455. Date of Electronic Publication: 2019 Aug 29.
DOI:	10.18549/PharmPract.2019.3.1455
Abstrakt:	Background: Skin cancer incidence is increasing alarmingly, despite current efforts trying to improve its early detection. Community pharmacists have proven success in implementing screening protocols for a number of diseases because of their skills and easy access. Objective: To evaluate the prevalence of skin cancer risk factors and the photoprotection habits with a questionnaire in community pharmacy users. Methods: A research group consisting of pharmacists and dermatologists conducted a descriptive cross-sectional study to assess photoprotection habits and skin cancer risk factors by using a validated questionnaire in 218 community pharmacies in Barcelona from May 23 rd to June 13 th 2016. All participants received health education on photoprotection and skin cancer prevention. Patients with ≥1 skin cancer risk factor were referred to their physician, as they needed further screening of skin cancer. Results: A total of 5,530 participants were evaluated. Of those, only 20.2% participants had received a total body skin examination for skin cancer screening in the past by a physician and 57.1% reported using a SPF 50+ sunscreen. 53.9% participants presented ≥1 skin cancer risk factor: 11.8% participants reported having skin cancer familial history and 6.2% reported skin cancer personal history; pharmacists found ≥10 melanocytic nevi in 43.8% participants and chronically sun-damaged skin in 21.4%. Lesions suspicious for melanoma were reported in 10.9% of the participants and urgent dermatological evaluation was recommended. Conclusions: Pharmacists can detect people with skin cancer risk factors amongst their users. This intervention can be considered in multidisciplinary strategies of skin cancer screening. Competing Interests: CONFLICT OF INTEREST JM and SP report personal fees for providing consultancy services, research and educational activities to BMS, MSD, Merk, AMGEN, Almirall, Leo Pharma, Novartis and Pierre-Fabre, outside the submitted work. The other authors have nothing to disclose. (Copyright: © Pharmacy Practice.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu